详情页 - 聚合机构库演示平台

资源类型：

文章类型：

作者：

Lai Wei[1] * ; Xiaoyun Xu[2] ; Yujuan Guan[3] ; Sujun Zheng[4] ; Jifang Sheng[5] ; Xingxiang Yang[6] ; Yuanji Ma[7] ; Yan Huang[8] ; Yi Kang[9] ; Xiaofeng Wen[10] ; JUN LI[11] ; Youwen Tan[12] ; Qing He[13] ; Qing Xie[14] ; Maorong Wang[15] ; Ping An[16] ; Guozhong Gong[17] ; Huimin Liu[18] ; Qin Ning[19] ; Rui Hua[20] ; Bo Ning[21] ; Wen Xie[22] ; Jiming Zhang[23] ; Wenxiang Huang[24] ; Yongfeng Yang[25] ; Minghua Lin[26] ; Yingren Zhao[27] ; Yanhong Yu[28] ; Jidong Jia[29]

; Dongliang Yang[30] ; Liang Chen[31] ; Yinong Ye[32] ; Yuemin Nan[33] ; Zuojiong Gong[34] ; Quan Zhang[35] ; Peng Hu[36] ; FuSheng Wang[37] ; Yongguo Li[38] ; Dongliang Li[39] ; Zhansheng Jia[40] ; Jinlin Hou[41] ; Chengwei Chen[42] ; Jinzi Wu[43] ;

单位： [1]Peking University People’s Hospital, Peking University Hepatology Institute, Beijing Key Laboratory for Hepatitis C and Immunotherapy for Liver Disease [2]Peking University People First Hospital [3]Guangzhou Eighth People’s Hospital [4]Beijing Youan Hospital, Capital Medical University [5]The First Affiliated Hospital of Medical School of Zhejiang University [6]Sichuan Provincial People’s Hospital [7]West China Hospital, Sichuan University [8]Xiangya Hospital, Central South University [9]Henan People’s Hospital [10]Liuzhou People’s Hospital [11]Department of Infectious Diseases, The First Affiliated Hospital with Nanjing Medical University [12]Zhenjiang No.3 People’s Hospital [13]The Third People’s Hospital of Shenzhen [14]Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China [15]Department of Infectious Diseases, No. 81 Hospital of People’s Liberation Army, Nanjing [16]Shenyang Sixth People’s Hospital [17]The Second Xiangya Hospital of Central South University, Changsha, China [18]Xixi Hospital of Hangzhou [19]Huazhong University of Science and Technology [20]Hepatology, The First Hospital of Jilin University [21]Baoji Center Hospital [22]Beijing Ditan Hospital, Capital Medical University, Beijing, China [23]Department of Infectious Diseases, Huashan Hospital Affiliated to Fudan University [24]Chongqing Medical University No.1 Affiliated Hospital [25]The Second Hospital of Nanjing [26]Fujian Fuzhou Municipal Infectious Disease Hospital [27]Department of Infectious Disease, The First Affiliated Hospital, Xi’an Jiaotong University,Xi’an, China [28]The First Affiliated Hospital of Guangxi Medical University [29]Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine in Liver Cirrhosis, National Clinical Research Center of Digestive Diseases, Beijing, China [30]Department of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology [31]Shanghai Public Health Clinical Center, Shanghai, China [32]Department of Infectious Diseases, Foshan First People’s Hospital [33]The Third Hospital of Hebei Medical University [34]Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, China [35]The Affiliated Hospital of Guizhou Medical University [36]The Second Affiliated Hospital of Chongqing Medical University [37]PLA 302 Hospital [38]The First Affiliated Hospital of Harbin Medical University [39]Fuzhou General Hospital of Nanjing Military Command [40]Tangdu Hospital [41]Nanfang Hospital [42]85th Hospital of People’s Liberation Army, Shanghai, China [43]Ascletis Bioscience Co., Ltd

出处：

ISSN：

语种：

WOS：

中科院(CAS)分区：

出版当年[2017]版：

大类 | 1 区

医学

小类 | 1 区胃肠肝病学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区胃肠肝病学

JCR分区：

出版当年[2016]版：

Q1 GASTROENTEROLOGY & HEPATOLOGY

最新[2023]版：

Q1 GASTROENTEROLOGY & HEPATOLOGY

第一作者：

第一作者单位： [1]Peking University People’s Hospital, Peking University Hepatology Institute, Beijing Key Laboratory for Hepatitis C and Immunotherapy for Liver Disease

推荐引用方式(GB/T 7714)：

APA：

MLA：

Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China

文献详情